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A
number of published guidelines exist on the
diabetic foot, yet the sections on Charcot neu-
roarthropathy (CN) focus mainly on diagnosis
and conservative therapy. Surgical aspects, if ever present,
are addressed very briefly and are very limited on surgical
information and guidelines (1). For this reason, a group
of German and Austrian foot surgeons who are well
acquainted with the operative treatment of CN estab-
lished a consensus statement despite a plethora of
existing diverging opinions. The following proposal is
far from scientific evidence, but may be the basis for an
ongoing discussion and further research opportunity.
Etiology of Charcot neuroarthropathy
Charcot neuroarthropathy is characterized by a predo-
minantly painless destruction of pedal bones and joints in
which the etiology is not entirely understood. A complex
compound of neuropathy, repeated trauma, hypervascu-
larization, and molecular-biological alterations of bone
metabolism may result in dramatic deterioration of the
foot skeleton. A distal symmetric polyneuropathy (PNP)
is conditio sine qua non for the development of neuroar-
thropathy. Diabetes mellitus is the most frequent under-
lying disease, yet sequelae of long-term alcohol abuse or
idiopathic cases should not be overlooked. Perhaps 80%
of all patients suffering from PNP have long-standing
diabetes mellitus. An additive effect of diabetic metabo-
lism and alcohol or nicotine as neurotoxins has not yet
been examined. Ischemic or idiopathic PNP are prevalent
in a small percentage of patients.
Neuropathy may affect different efferent and afferent
nerve fibers; first, sensory neuropathy interfering with the
receptor-activated nuclear factor kappa-ligand/osteopro-
tegerin (RANK-L/OPG) system as a possible explanation
for an unleashed inflammatory response to a minor
trauma or repetitive stress (2). Secondly, autonomic
neuropathy with dysfunctional vascular control and
opened arteriovenous shunts as a possible reason for
local osteoporosis and lastly, motor neuropathy with
paresis of intrinsic foot musculature and consequent
development of foot deformity (claw toes, high arched
foot) as a reason for increased static and dynamic
loading.
The diabetic foot syndrome comprises three clinical
subgroups: peripheral vascular disease (PVD) in 25%,
PNP in 25%, and a combination of PVD and PNP in 50%.
CN, where PNP is always present (although not always
noticeable on clinical examination), has an estimated
incidence of 7% per year among diabetics with PNP, as
recently published by a major German health insurer on
the basis of data collected in 2007. In the German
situation, this translates to about 5,000 cases emerging
every year (3). Stuck et al. (4) reported an annual
incidence of 1.2% in a cohort of diabetics with increasing
incidence of CN in the presence of PNP or obesity.
Coexistence of PVD may occur with long-standing CN
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CN in the general population is comparable to malig-
nancies and makes the high frequency of misdiagnosis
understandable. Sohn reported a 5-year mortality rate of
28.3% among patients with CN (5).
Classification of Charcot neuroarthropathy
Charcot neuroarthropathy is classified based on the
topography of affected joints, course of the disease, and
patterns of destruction. In this consensus, localization is
classified according to the Sanders system (6). The
simplicity and practicality of this system implies its
limitations, when more than one joint line is involved
or when the topographic pattern deviates from anatomi-
cal lines (e.g. Lisfranc, Chopart). The Sanders classifica-
tion system does not allow for deduction of a specific
operative procedure based on a given radiological CN
pattern.
Another important classification was established by
Eichenholtz in 1966 describing destruction as well as
repair of joints and bone in the course of time (7). This
clinical and radiographic staging system has been well
accepted internationally, delineating three distinct stages:
(1) destruction, (2) resolution, and (3) coalescence.
A prodromal Stage 0 could represent a sensible modifica-
tion in cases of bone bruise apparent on magnetic
resonance imaging (MRI) without manifest changes on
plain film radiographs. The denomination ‘Stage 0’ might
underestimate a serious problem; therefore, another
proposal is to subdivide Stage 1 into ‘1a’ with clinical
signs of inflammation and bone bruise on MRI plus ‘1b’
with additional osseous destruction visible on conven-
tional radiographs.
Ulcers often accompanying CN are best classified
using the University of Texas Wound Classification
System that describes ulcer depth and the presence of
inflammation, ischemia, and/or PNP (8). Risk of ampu-
tation correlates well with the more severe stages (3D).
Category E should be introduced in case of dialysis, as
practical experience shows a high failure rate of con-
servative ulcer treatment when end stage renal disease is
present. An ulcerated CN foot should be characterized by
means of Sanders, Eichenholtz, and the University of
Texas Wound Classification System.
Diagnosis of Charcot neuroarthropathy
Combination of medical history, clinical examination,
and conventional radiography (anteroposterior, lateral,
and mortise views) is sufficient for making the diagnosis
of CN. Affected bones and the extent of bone bruise can
be identified precisely with the help of MRI. Any
suspicion of Eichenholtz Stage 0 or 1a, respectively,
must include MRI or scintigraphy in addition to plain
film radiographs. Clinical significance of bone bruise as
incidental findings in patients with diabetic PNP remains
unclear, in particular with regard to potential develop-
ment of CN. Uncertainty also exists in terms of estimat-
ing safe loading capacity of Charcot feet with the help of
MRI, as many of those feet with destructed joints will
retain a life-long inflammatory activity due to degenera-
tive changes. Last but not the least, distinction between
CN and osteomyelitis remains difficult on the basis of
radiological examination alone.
Specimen for microbiological testing should be taken
from deep tissue, preferably from bone and through
intact, non-contaminated skin under sterile conditions.
Laboratory testing does not always facilitate a distinction
between acute CN and osteomyelitis or abscess forma-
tion, as on the one hand acute CN is often accompanied
by leukocytosis and elevated C-reactive protein. On the
other hand, osteomyelitis may demonstrate only vague
signs of inflammation due to ischemia or immunodefi-
ciency (HbA1c  11%).
As a complex correction of a deformed Charcot foot
may turn into a catastrophe in the presence of relevant
ischemia, the absence of palpable pulses must imply
vascular examination ranging from Doppler sonography
to invasive arteriography.
Therapy of Charcot neuroarthropathy  basic
principles
Therapy of CN is often conservative. A deformed but
plantigrade foot capable of full weight bearing in a shoe
or orthosis and without increase of deformity is not a
candidate for surgery. There are a variety of devices
available for conservative treatment. Each device, such as
total contact cast (TCC), prefabricated walker, Charcot
Restraint Orthotic Walker (CROW), or individual ankle
foot orthosis (AFO), has a different risk-benefit profile
and has to be selected by the treating physician. Injuries
due to ill-fitting orthoses or shoes may create an immense
medical and financial burden.
An acute Charcot foot may call for in-patient treatment
or off-loading by means of a wheelchair over a period of
68 weeks. After decrease in the acute inflammatory stage,
total weight relief may be replaced by orthotic treatment
with particular emphasis on rigid three-dimensional
fixation of the foot and lower leg including elimination
of tibial rotation. Physical load is gradually increased
according to clinical parameters monitoring swelling,
redness, and sensible heat. Resumption of walking as
soon as possible protects against loss of bone mineral
density, thereby reducing cadence andwalking speedwhen
using the orthosis. Partial weight bearing is not feasible in
the presence of PNP. Thus, guidance of weight bearing
takes place by limitation of walking time and speed.
Knowledge on the field of rehabilitation with shoes and
orthoses is extremely helpful.
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Closed reduction and retention by means of casting is
ineffective in cases of acute CN with joint dislocation and
significant instability. This subtype of CN can only be
managed by open reduction with internal or external
fixation (ORIF or OREF).
From a biomechanical point of view, the two-column
model of the foot has to be taken into account. Fusion of
the lateral column should be considered, even if the
problem is confined to the medial column only. As soon
as conservative treatment signals an unfavorable out-
come, reconstructive surgery should take place without
waiting for Eichenholtz Stage 3, where deformity has
become fixed and rigid. Ulcers are not necessarily an
obstacle to surgery. An infected ulcer, however, should be
treated first with debridement, moist dressings, and
antibiotics. Bony prominences with high risk of ulcer
occurrence or reoccurrence should be excised, preferably
via a direct surgical approach or from the lateral or
medial foot border. Vast soft tissue defects are treated in
the scope of plastic surgery. Infected Charcot feet are the
worst case scenario. To be precise, treatment is no longer
targeted to neuroarthropathy but has to follow the rules
of septic surgery. Even amputations or wide internal
resections may be necessary.
The aim of surgery is to correct deformities in all three
planes. The frontal and transverse planes are more
important than the sagittal plane. Mild equinus position
of the foot may even be useful to correct for a shortened
limb due to loss of bone stock. On the other hand, CN of
the tarsal bones may be in part a result of a shortened
Achilles tendon. In this case and in the presence of a
mobile ankle joint, tendoachilles lengthening (TAL)
should be considered. Adequate technique, for example
intramuscular lengthening, is important to avoid calca-
neal foot position with the risk of heel ulcers. Preferably,
osseous corrections are performed in a subtractive rather
than in an additive fashion. Allogenic cancellous bone or
synthetic bone substitutes cannot be recommended with-
out reservation, although use of autologous graft is not
stringently required.
To avoid disuse osteoporosis, total off-loading should
be reduced to an unavoidable duration of 68 weeks. The
use of circular frames may even permit early weight
bearing with the appliance. Bone fusion can be evaluated
by computed tomography or conventional radiographs.
After internal fixation or after removal of an external
fixation device, the foot has to be protected from bending
and torque forces by means of an AFO that is generally
worn over a period of 36 months. The device is designed
for rigid fixation of the foot and full weight bearing, as
patients with PNP cannot practice partial weight bearing.
Operative therapy of Charcot feet
Eichenholtz’s or Sanders’ classification does not enable a
clear association of deformity patterns and operative
techniques. Nevertheless, the Sanders classification is
very common, therefore it is used for the following
overview.
Sanders I
Type I affects the metatarsophalangeal (MTP) and the
interphalangeal joints. The natural course of this type is
different from the other four. The percentage of patients
with PVD is significantly higher, whereas body mass
index is not so much elevated. When the MTP joints are
involved, bone changes are predominantly resorptive
leading to the so-called candy stick deformity of the
metatarsals. Reconstructive surgery in these cases is
rarely indicated. Dislocation of the first MTP joint may
require repositioning and fusion. For the most part,
resections of bone in this type are performed due to
severe destructions or superimposed infections.
Sanders II
Type II frequently affects the tarsometatarsal articula-
tions (Lisfranc). A rather common variation is peri-
navicular involvement, and sometimes the neuroarthro-
pathic changes are restricted to the medial or the lateral
column. Diverging dislocations are seen as well as
deviations of all metatarsals to the medial or lateral
side. A frequent pattern of deformity with this type of
CN is forefoot abduction together with a flattened medial
arch and heel valgus. In case of Eichenholtz Stage 3 and
stable tarsal joints, realignment is possible by means of
two- or three-dimensional wedge resection. Pure medial
fusion may be indicated if the lateral column is spared.
Repositioning and achievement of stable fusion may be
technically demanding in case of dislocation of all five
metatarsals in all directions. Another common pattern is
naviculo-cuneiform dislocation with plantar flexion of
the talus with the navicular and dorsal dislocation of the
first metatarsal with the medial cuneiform. Unresisted
pull of the anterior tibial muscle may lead to progressive
fragmentation and displacement making conservative
treatment even under strict non-weight bearing condi-
tions ineffective, so that early operative intervention may
be indicated to restore stability of the medial column.
Disagreement exists with respect to the optimal method
of fixation, be it a frame, internal osteosynthesis, or a
combination of both. There is a consensus that a
particular stable fixation is necessary just as for Charcot
surgery in general and different from traditional trauma
surgery. As any operation in case of Eichenholtz Stage 3
may lead to an acute exacerbation of neuroarthropathy,
postoperative immobilization is obligatory by means of a
cast or an AFO over a period of several months.
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By definition, Stage III involves the midtarsal (Chopart)
joint line. Presentation in combination with type II is
quite common. A typical deformity pattern for isolated
type III is a rocker bottom foot with the cuboid being the
lowest lying part of the foot skeleton. As the talonavi-
cular joint holds a key role for biomechanics, coupling
the movements of foot and lower leg, exact reduction and
fixation are challenging as much as essential. Even if the
talonavicular joint shows the most evident extent of
dislocation, reduction and fusion of this joint alone is
hardly ever sufficient. At the very least, inclusion of the
subtalar joint is advisable to minimize rotational forces
acting on the talus. In cases of doubt, triple arthrodesis is
a guarantor for successful stabilization. Length compen-
sation between medial and lateral column requires
subtractive arthrodeses.
Sanders IV
In Sanders IV, the ankle joint and subtalar joint are
impaired. Frontal plane deformities in the region of the
hindfoot are hard to manage conservatively, particularly
in cases of instability. Surgery aims at solid ankle fusion
with broad contact area. Talectomy may be a valuable
option in the event of an extensive and rigid deformity to
overcome soft tissue contracture. Tibio-calcaneal ar-
throdesis requires a months-long duration of orthotic
after treatment with axial loading of the hindfoot. In
terms of functionality, stable fibrous ankylosis is not
necessarily inferior to complete bony fusion, as PNP
allows pain-free walking in custom-made shoes.
Sanders V
Sanders V involves the calcaneus and constitutes the
rarest type of CN. As long as the deformity is stagnant,
conservative therapy is favorable, in particular in case of
poor calcaneal bone quality with no support for screws or
pins. If fragment distance of a calcaneal fracture is
increasing due to pull of the Achilles tendon, treatment
in a CROWor an AFO is ineffective or leads to a marked
deformity. Again, surgery can be performed with a frame
or with internal osteosynthesis, in particular with an
intramedullary nail. If a nail has caused complications
like septic or aseptic loosening with or without fracture,
revision surgery can be done with external fixation. In
case of impaired skeletal anchorage due to loss of bone
substance, external fixation surgery may be considered as
the primary treatment option.
Conclusion
This perspective is not a scientific review, nor the least
common denominator within a group of diabetic foot
surgeons. It is an attempt to develop a future-oriented
consensus based on existing scientific literature as well as
personal experience. As additional studies continue to
expand the knowledge available for operative treatment
of CN and its outcomes, more definitive evidence-based
recommendations may be established.
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